These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34347158)

  • 1. Influence of post-label delay time on the performance of 3D pseudo-continuous arterial spin labeling magnetic resonance imaging in the characterization of parotid gland tumors.
    Hu H; Chen L; Zhu LN; Chen W; Su GY; Dou W; Bu SS; Wu FY; Xu XQ
    Eur Radiol; 2022 Feb; 32(2):1087-1094. PubMed ID: 34347158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
    Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
    Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
    Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
    Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
    Razek AAKA
    Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
    Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
    Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.
    Wei PY; Shao C; Huan T; Wang HB; Ding ZX; Han ZJ
    Clin Radiol; 2021 Jun; 76(6):472.e19-472.e25. PubMed ID: 33731262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.
    Kato H; Kanematsu M; Watanabe H; Kajita K; Mizuta K; Aoki M; Okuaki T
    Eur Radiol; 2015 Nov; 25(11):3247-54. PubMed ID: 25921591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional, diffusion, and dynamic contrast-enhanced MRI findings for differentiating metaplastic Warthin's tumor of the parotid gland.
    Jia CH; Wang SY; Li Q; Qiu JM; Kuai XP
    Sci Prog; 2021; 104(2):368504211018583. PubMed ID: 34003684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
    Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
    Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
    Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
    Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of pre-/post-contrast-enhanced T1 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging in differentiating parotid gland tumors.
    Wen B; Zhang Z; Fu K; Zhu J; Liu L; Gao E; Qi J; Zhang Y; Cheng J; Qu F; Zhu J
    Eur J Radiol; 2023 May; 162():110748. PubMed ID: 36905715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
    Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
    NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
    Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
    Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
    Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
    Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors.
    Huang N; Chen Y; She D; Xing Z; Chen T; Cao D
    Eur Radiol; 2022 Apr; 32(4):2748-2759. PubMed ID: 34642805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors.
    Wang Y; Hu H; Ban X; Jiang Y; Su Y; Yang L; Shi G; Yang L; Han R; Duan X
    Acad Radiol; 2024 May; 31(5):2027-2038. PubMed ID: 37730491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: ultrasonographic features.
    Rong X; Zhu Q; Ji H; Li J; Huang H
    Acta Radiol; 2014 Dec; 55(10):1203-9. PubMed ID: 24324278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical Characteristics and CT Findings of Parotid and Submandibular Gland Tumours.
    Zuo H
    J Oncol; 2021; 2021():8874100. PubMed ID: 34306079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parotid Warthin's tumor: novel MR imaging score as diagnostic indicator.
    Luna LP; Coffey W; Alvin MD; Shanechi AM; Sankaran N; Rodriguez EF; Naeem Z; Aygun N; Khan M
    Clin Imaging; 2022 Jan; 81():9-14. PubMed ID: 34598007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Three-dimensional Pseudo-continuous Arterial Spin Label Non-contrast Enhanced Perfusion Imaging of Head and Neck Tumors with High-field MR System].
    Chen Y; Duan M; Zhou HL; Shi KN; Sun ZY; Bai CM; Jia N; Zhang T; Chen XM; Hu K; Zhang ZH; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Oct; 37(5):567-74. PubMed ID: 26564509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.